In one sentence: After Phil's riding accident, the two spend most of the episode on injuries and then a first-pass look at Glanbia, the Irish nutrition and cheese roll-up: an odd board, accountant managers, strong returns, and an open question about its moat.
Key ideas
- Off-topic opening. About 14 minutes cover Phil's fall from a horse and a broken collarbone and rib, and his rehab. Only the Glanbia section is investing content. [00:00–14:00]
- First step: can I understand it? Phil's reading of the website suggests three parts: performance nutrition, nutraceuticals and cheese. The cheese co-op legacy funded buying US firms. [14:00–17:00]
- The board. Several of about 11 directors are farmers tied to the former co-op, which holds about 30% of the shares. He called it a red flag (dead or negative space), and Danielle questioned how much to infer from guesses. [16:00–21:00]
- Ask relevant questions. A mentor's story: investors judging farms by trivial questions, like asking about a date's fingernails. If you don't know what to ask, it's outside your circle for now, not forever. [21:00–23:00]
- Accountants in charge. Phil found nearly all of management are accountants. He wondered whether it is cultural, and whether number-crunchers suit a roll-up strategy. [23:00–26:30]
- Number one by revenue. He says it is now the largest performance-nutrition company in the US by buying small brands. [26:00–28:00]
- Foreign reports can be better. Danielle compares Exor in the Netherlands; both found fuller disclosure than US filings. [28:00–30:00]
- Valuation hint. Phil says it trades near a "10 cap" (about ten times owner earnings), and is wary because the price hasn't dropped recently. The usual cause of a bargain is a recent problem; otherwise it may be a plain commodity-style business with no moat. [30:00–32:00]
- The open question. What is the moat? To be dug into next. [31:00–32:30]
How it maps to RuleOne
- Glanbia is a live example of the process: understand, then moat, then price. It's not in the US screen, so the numbers must be gathered by hand.
- The "no recent price drop" doubt matches the screen's event-watch logic: cheap without an event deserves skepticism.
Buffett, Munger and Graham links
- Munger's four filters (001) run in order; the board point belongs to management.
- Buffett's warning that cheap can be a poor business (1989 letter on the "cigar butt") fits the commodity worry.
Words to know
- Roll-up: growing by buying many smaller companies in one industry.
- Nutraceutical: a food-derived product sold for health benefits.
- 10 cap: price of about ten times owner earnings, an earnings yield of about 10%.
Try this
Open the 10-K or annual report of a company that grows by acquisitions. Find the share of equity that is goodwill or intangibles and read the note on its last purchase.
Check yourself
- Why was a farmer-heavy board a flag for Phil?
Answer
He thought farmers add little to a nutrition strategy, so the seats look like dead or negative space, though he admitted it was inference. - Why does a cheap price without a recent drop worry him?
Answer
It may not be on sale for an identifiable event and may simply be a no-moat commodity business.
Short quotes
"I'm skeptical that I'm looking at something on sale." (Phil, ~31:00, auto-transcribed)